Zobrazeno 1 - 10
of 503
pro vyhledávání: '"Won-keun Kim"'
Autor:
Maren Weferling, Andreas Rolf, Julia Treiber, Ulrich Fischer-Rasokat, Christoph Liebetrau, Christian W. Hamm, Damini Dey, Won-Keun Kim
Publikováno v:
BMC Cardiovascular Disorders, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Background Primary coronary slow flow (CSF) is defined as delayed opacification of the distal epicardial vasculature during coronary angiography in the absence of relevant coronary artery stenoses. Microvascular disease is thought to be the
Externí odkaz:
https://doaj.org/article/77510f9a0d414ffd8ea809d631bf30fc
Autor:
Samuel M. Goodfellow, Robert A. Nofchissey, Dustin Arsnoe, Chunyan Ye, Seonghyeon Lee, Jieun Park, Won-Keun Kim, Kartik Chandran, Shannon L.M. Whitmer, John D. Klena, Jonathan W. Dyal, Trevor Shoemaker, Diana Riner, Mary Grace Stobierski, Kimberly Signs, Steven B. Bradfute
Publikováno v:
Emerging Infectious Diseases, Vol 30, Iss 4, Pp 817-821 (2024)
Orthohantaviruses cause hantavirus cardiopulmonary syndrome; most cases occur in the southwest region of the United States. We discuss a clinical case of orthohantavirus infection in a 65-year-old woman in Michigan and the phylogeographic link of par
Externí odkaz:
https://doaj.org/article/2c232580dfc54b1880ae53b6821705bc
Autor:
Taehun Lim, Shivani Rajoriya, Bohyeon Kim, Augustine Natasha, Hyeonjoo Im, Hyun Soo Shim, Junsang Yoo, Jong Woo Kim, Eun-Woo Lee, Hye Jin Shin, Soon Ha Kim, Won-Keun Kim
Publikováno v:
Virus Research, Vol 342, Iss , Pp 199325- (2024)
The COVID-19 pandemic caused by SARS-CoV-2 becomes a serious threat to global health and requires the development of effective antiviral therapies. Current therapies that target viral proteins have limited efficacy with side effects. In this study, w
Externí odkaz:
https://doaj.org/article/808e3e370a074b309e11d12619df0274
Autor:
Sofia Sammartino, Giulia Laterra, Thomas Pilgrim, Ignacio J. Amat Santos, Ole De Backer, Won-Keun Kim, Henrique Barbosa Ribeiro, Francesco Saia, Matjaz Bunc, Didier Tchetche, Philippe Garot, Flavio Luciano Ribichini, Darren Mylotte, Francesco Burzotta, Yusuke Watanabe, Francesco Bedogni, Tullio Tesorio, Tobias Rheude, Gennaro Sardella, Marco Tocci, Anna Franzone, Roberto Valvo, Mikko Savontaus, Hendrik Wienemann, Italo Porto, Caterina Gandolfo, Alessandro Iadanza, Alessandro Santo Bortone, Markus Mach, Azeem Latib, Luigi Biasco, Maurizio Taramasso, Federico De Marco, Valentina Frittitta, Elena Dipietro, Claudia Reddavid, Orazio Strazzieri, Silvia Motta, Alessandro Comis, Chiara Melfa, Mariachiara Calì, Carmelo Sgroi, Mohamed Abdel-Wahab, Giulio Stefanini, Corrado Tamburino, Marco Barbanti, Giuliano Costa
Publikováno v:
Journal of Clinical Medicine, Vol 13, Iss 12, p 3497 (2024)
Background/Objectives: To date, data regarding the characteristics and management of obstructive, stable coronary artery disease (CAD) encountered in patients undergoing transcatheter aortic valve implantation (TAVI) are sparse. The aim of the study
Externí odkaz:
https://doaj.org/article/5605af894431485b929cbde12eff87d8
Autor:
Timm Ubben, Eike Tigges, Won-Keun Kim, Andreas Holzamer, Ingo Breitenbach, Ralf Sodian, Jürgen Rothe, Willibald Hochholzer, Samer Hakmi, Franz-Josef Neumann
Publikováno v:
Journal of Clinical Medicine, Vol 13, Iss 11, p 3163 (2024)
Background: The primary objective of this study was to evaluate the initial experience in Germany with the Meril Myval™ (MM) transcatheter heart valve (THV) system for the treatment of severe symptomatic aortic valve stenosis. The MM THV is a novel
Externí odkaz:
https://doaj.org/article/3a1b4c93b71340558195883f288ad96d
Autor:
Helge Möllmann, MD, Axel Linke, MD, Luis Nombela-Franco, MD, Martin Sluka, MD, Juan Francisco Oteo Dominguez, MD, Matteo Montorfano, MD, Won-Keun Kim, MD, Martin Arnold, MD, Mariuca Vasa-Nicotera, MD, Stephan Fichtlscherer, MD, Lenard Conradi, MD, Anthony Camuglia, MD, Francesco Bedogni, MD, Keshav Kohli, PhD, Ganesh Manoharan, MD
Publikováno v:
Structural Heart, Vol 8, Iss 1, Pp 100226- (2024)
Background: The CONtrolled delivery For ImproveD outcomEs with cliNiCal Evidence registry was initiated to characterize the clinical safety and device performance from experienced transcatheter aortic valve implantation (TAVI) centers in Europe and A
Externí odkaz:
https://doaj.org/article/a9590bd9804d43ea91db624671a2b836
Autor:
Won-Keun Kim, MD, PhD, Chris Frawley, BSME, Efstratios I. Charitos, MD, PhD, Arif A. Khokhar, BM, BCh
Publikováno v:
JACC: Case Reports, Vol 28, Iss , Pp 102118- (2023)
We demonstrate a modified technique of heterotopic chimney stenting for coronary obstruction during valve-in-valve transcatheter aortic valve replacement With successful end-on cannulation via the stent ostium. Our technique was reproducible on the b
Externí odkaz:
https://doaj.org/article/615ac8182bb743d3b279f70798d42a17
Autor:
Ulrich Fischer-Rasokat, Matthias Renker, Efstratios I. Charitos, Christopher Strunk, Julia Treiber, Andreas Rolf, Maren Weferling, Yeong-Hoon Choi, Christian W. Hamm, Won-Keun Kim
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 10 (2023)
AimsCardiac decompensation (CD) in patients with aortic stenosis is a “red flag” for future adverse events. We classified patients undergoing transcatheter aortic valve implantation (TAVI) into those with acute, prior, or no prior CD at the timep
Externí odkaz:
https://doaj.org/article/7a6c742f41c047bb8c553589800967b4
Autor:
Andreas Rück, Won‐Keun Kim, Mohamed Abdel‐Wahab, Holger Thiele, Tanja K. Rudolph, Alexander Wolf, Jan Martin Wambach, Ole De Backer, Lars Sondergaard, Christian Hengstenberg, Mika Laine, Hirokazu Miyashita, Henrik Bjursten, Matthias Götberg, Costanza Pellegrini, Stefan Toggweiler, Joanna J. Wykrzykowska, Osama Soliman, Nawzad Saleh, Christopher U. Meduri
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 12, Iss 15 (2023)
Background ACURATE neo2 is a transcatheter aortic valve implantation system consisting of a self‐expanding bioprosthetic valve with supra‐annular leaflet position and featuring innovations to facilitate placement accuracy and reduce paravalvular
Externí odkaz:
https://doaj.org/article/d957a477057f4b349435dda9ef347c1e
Autor:
Mahmoud Abdelshafy, Patrick W. Serruys, Tsung-Ying Tsai, Pruthvi Chenniganahosahalli Revaiah, Scot Garg, Jean-Paul Aben, Carl J. Schultz, Mohammad Abdelghani, Pim A. L. Tonino, Yosuke Miyazaki, Marcel C. M. Rutten, Martijn Cox, Cherif Sahyoun, Justin Teng, Hiroki Tateishi, Mohamed Abdel-Wahab, Nicolo Piazza, Michele Pighi, Rodrigo Modolo, Martijn van Mourik, Joanna Wykrzykowska, Robbert J. de Winter, Pedro A. Lemos, Fábio S. de Brito, Hideyuki Kawashima, Lars Søndergaard, Liesbeth Rosseel, Rutao Wang, Chao Gao, Ling Tao, Andreas Rück, Won-Keun Kim, Niels van Royen, Christian J. Terkelsen, Henrik Nissen, Matti Adam, Tanja K. Rudolph, Hendrik Wienemann, Ryo Torii, Franz Josef Neuman, Simon Schoechlin, Mao Chen, Ahmed Elkoumy, Hesham Elzomor, Ignacio J. Amat-Santos, Darren Mylotte, Osama Soliman, Yoshinobu Onuma
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 10 (2023)
Paravalvular leak (PVL) is a shortcoming that can erode the clinical benefits of transcatheter valve replacement (TAVR) and therefore a readily applicable method (aortography) to quantitate PVL objectively and accurately in the interventional suite i
Externí odkaz:
https://doaj.org/article/44d275368d6f4cc5b7aa5e0f5c4469f3